Tremedics Medical Devices

Tremedics is a private U.S. medical device company developing bioresorbable vascular stent technology for children with congenital heart disease. Its lead product, Illusicor, is a polymer-based stent designed to be delivered through minimally invasive procedures and then gradually resorb as pediatric patients grow, with the goal of reducing repeat surgeries associated with permanent metal stents. The company appears focused primarily on cardiovascular device innovation rather than therapeutics or drug development. Tremedics has participated in startup and accelerator ecosystems including MassChallenge and has received recognition for its pediatric heart stent innovation. The business is best characterized as an early-stage pediatric medtech company commercializing resorbable stent technology.